Latest formulary decision guides

  • FINAL Doublebase Pic
    Formulary decision guide

    Doublebase Dayleve™ Gel (isopropyl myristate, liquid paraffin)

    2019-07-09T07:08:00Z Commissioned by Dermal Laboratories Ltd

    Information intended for healthcare professionals only. This formulary decision guide was developed from content provided by Dermal Laboratories Ltd in a format developed by Guidelines in Practice . View prescribing information and adverse event reporting here Key points Doublebase Dayleve Gel ...

  • Final version_Jardiance FDG update
    Formulary decision guide

    Jardiance® (empagliflozin) film-coated tablets

    Promotional material from Boehringer Ingelheim Limited and Lilly Diabetes Alliance

    This formulary decision guide was initiated, funded, and reviewed by Boehringer Ingelheim Limited and Lilly Diabetes Alliance. The format was developed by Guidelines in Practice. View prescribing information Key points on this medicine Jardiance: is a once-daily SGLT2 inhibitor that improves ...

  • Stalpex UPDATE_v2
    Formulary decision guide

    Stalpex (salmeterol xinafoate/fluticasone propionate)

    2019-05-08T08:03:00Z Commissioned by Glenmark Pharmaceuticals Europe Ltd

    Information intended for healthcare professionals only. This formulary decision guide was developed from content provided by Glenmark Pharmaceuticals Europe Ltd in a format developed by Guidelines in Practice . View prescribing information here Key points Stalpex is a branded generic inhaled ...

  • Final version - Nutramigen 1,2 & 3 FDG
    Formulary decision guide

    Nutramigen™ 1, 2 & 3 with LGG®

    2019-04-18T13:58:00Z Commissioned by Mead Johnson Nutrition

    Information intended for healthcare professionals only. This formulary decision guide was developed from content provided by Mead Johnson Nutrition in a format developed by Guidelines in Practice . Key points CMA is the most common childhood food allergy affecting 1.9–⁠4.9% of infants ...

  • Soprobec FDG final image
    Formulary decision guide

    Soprobec (beclometasone dipropionate) pMDI

    2019-04-04T07:32:00Z Commissioned by Glenmark Pharmaceuticals Europe Ltd

    Information intended for healthcare professionals only. This formulary decision guide was developed from content provided by Glenmark Pharmaceuticals Europe Ltd in a format developed by Guidelines in Practice . View prescribing information here Key points Soprobec is a generic CFC-free beclometasone ...

  • 20190319 Symbicort FDG Online thumbnail
    Formulary decision guide

    Symbicort® (budesonide/formoterol) for COPD

    Commissioned by AstraZeneca

    Information intended for healthcare professionals only. This formulary decision guide was commissioned by AstraZeneca UK Ltd, who had full editorial control, and was produced in a format developed by Guidelines in Practice . Indications Symbicort pMDI 200 μg/6 μg per actuation, pressurised inhalation suspension, Symbicort ...

  • Puramino FDG image final
    Formulary decision guide

    Nutramigen™ PURAMINO™

    2019-03-14T11:37:00Z Commissioned by Mead Johnson Nutrition

    Information intended for healthcare professionals only. This formulary decision guide was developed from content provided by Mead Johnson Nutrition Ltd in a format developed by Guidelines in Practice . Key points Cow’s milk allergy (CMA) is a common yet complex food allergy, ...

  • FDG - Methofill
    Formulary decision guide

    Methofill® (methotrexate) Self Inject

    2019-02-18T08:26:00Z Commissioned by Accord UK Ltd

    Information intended for healthcare professionals only. This formulary decision guide was developed from content provided by Accord UK Ltd in a format developed by Guidelines in Practice . View prescribing and adverse event reporting information here Key points Methofill ® ...

  • Final version - Semglee FDG_reprint
    Formulary decision guide

    Semglee® ▼ (insulin glargine biosimilar)

    2019-01-07T08:39:00Z Commissioned by Mylan

    This formulary decision guide was developed from content provided by Mylan Ltd in a format developed by Guidelines in Practice .

  • Spiriva Respimat FDG
    Formulary decision guide

    Spiriva® Respimat® (tiotropium)

    2018-12-12T11:44:00Z Commissioned by Boehringer Ingelheim Limited

    Information intended for healthcare professionals only. This formulary decision guide was developed from content provided by Boehringer Ingelheim Limited in a format developed by Guidelines in Practice . Boehringer Ingelheim Limited reviewed the content for compliance with the ABPI code of practice. View prescribing information here ...